
Contact us
About company
Changing the game. Tolerogenics S.à.r.l. has developed several key technologies to overcome today’s bottlenecks in immunotherapy treatment. Tolerogenic’s has used these technologies to create a novel patent-protected approach of tolerance induction to achieve long-term cure of allergy diseases. The experienced management of Tolerogenics will provide the strategic and regulatory support to bring the products to market.
DE
Unknown
Not verified company